| Regioselective C–H alkylation and alkenylation at the C5 position of 2-amino-1, 4-naphthoquinones with maleimides under Rh (iii) catalysis PA Yakkala, D Giri, B Chaudhary, P Auti, S Sharma Organic Chemistry Frontiers 6 (14), 2441-2446, 2019 | 33 | 2019 |
| Rh (III)-catalyzed [3+ 2] annulation via C–H activation: Direct access to trifluoromethyl-substituted indenamines and aminoindanes B Chaudhary, P Auti, SD Shinde, PA Yakkala, D Giri, S Sharma Organic letters 21 (8), 2763-2767, 2019 | 28 | 2019 |
| Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents PA Yakkala, NR Penumallu, S Shafi, A Kamal Pharmaceuticals 16 (10), 1456, 2023 | 17 | 2023 |
| Pyridine-based 1, 2, 4-triazolo-tethered indole conjugates potentially affecting TNKS and PI3K in colorectal cancer PA Yakkala, SR Panda, VGM Naidu, S Shafi, A Kamal ACS Medicinal Chemistry Letters 14 (3), 260-269, 2023 | 11 | 2023 |
| Synthesis and Cytotoxic Activity of 1,2,4-Triazolo-Linked Bis-Indolyl Conjugates as Dual Inhibitors of Tankyrase and PI3K PA Yakkala, SR Panda, S Shafi, VGM Naidu, MS Yar, PN Ubanako, ... Molecules 27 (21), 7642, 2022 | 9 | 2022 |
| Novel approaches for the development of direct KRAS inhibitors: structural insights and drug design K Haider, A Sharma, MS Yar, PA Yakkala, S Shafi, A Kamal Expert Opinion on Drug Discovery 17 (3), 247-257, 2022 | 6 | 2022 |
| Multicomponent Domino Reaction for Concise Access to 2-Amino-Substituted 1, 3, 4 Oxadiazoles via Smiles Rearrangement PA Yakkala, IA Khan, SR Dannarm, J Aboti, R Sonti, S Shafi, A Kamal The Journal of Organic Chemistry 88 (17), 12216-12223, 2023 | 2 | 2023 |
| 5‐Arylidene‐2,4‐thiazolidinediones as Cysteine Protease Inhibitors against Leishmania Donovani S Sharma, P Anjaneyulu Yakkala, MA Beg, S Tanwar, I Latief, A Khan, ... ChemistrySelect 8 (29), e202302415, 2023 | 2 | 2023 |
| Design and Synthesis of Michael Acceptor‐Based Peptidyl β‐Nitrostyrenes as 3CLpro Inhibitors of SARS‐CoV‐2 S Sharma, PA Yakkala, J Aboti, I Latief, MA Ansari, WH Khan, S Shafi ChemistrySelect 8 (24), e202300912, 2023 | 2 | 2023 |
| PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer PA Yakkala, F Naaz, S Shafi, A Kamal Expert Opinion on Therapeutic Targets 28 (3), 159-177, 2024 | 1 | 2024 |
| Oxindoline Containing Thiazolidine‐4‐one Tethered Triazoles Act as Antimitotic Agents by Targeting Microtubule Dynamics S Shahjahan, LT Naraharisetti, A Begum, PA Yakkala, ... ChemistrySelect 9 (17), e202400539, 2024 | | 2024 |
| An update on the development on tubulin inhibitors for the treatment of solid tumors PA Yakkalaa, S Rahaman, PSL Soukya, SA Begum, A Kamal Expert Opinion on Therapeutic Targets 28 (3), 193-220, 2024 | | 2024 |
| Development and Evaluation of Bis-benzothiazoles as a New Class of Benzothiazoles Targeting DprE1 as Antitubercular Agents R Samoon, S Sau, A Roy, KK Parida, K Sharma, PA Yakkala, ... ACS Infectious Diseases, 2024 | | 2024 |
| Synthesis and Development of Heterocyclic Hybrids as Potential Anti Cancer Agents YP Anjaneyulu Delhi, 0 | | |
syed shafiJamia Hamdard, New Delhi (India)在 jamiahamdard.ac.in 的电子邮件经过验证
